An interministerial committee of the Israeli Finance and Health Ministries has approved the export of medical marijuana by licensed businesses. The committee examined the economic, legal, and regulatory implications of medical marijuana exports and found that there was a strong economic advantage in allowing the exports. They also found that the country's advanced regulation, research, and clinical experience with medical marijuana would ensure a strong demand for Israeli cannabis products.
Israel currently has eight licensed growers to serve the country's 30,000 medical marijuana patients. So far, over 500 growers have applied for a license to grow medical cannabis for export. The committee recommended that medical cannabis exports should be regulated heavily by the Health Ministry, and that only licensed cultivators should produce items for export. All forms of cannabis products, from flower to edibles to oils, will be eligible for export, but can only be exported to countries where medical marijuana is legal.
“The export of medical cannabis is an industry with significant economic potential for the State of Israel and will strengthen Israeli agriculture,” Finance Minister Moshe Kahlon said. “It will serve as an opportunity for the country to exploit its relative advantage in developing medical products from medical cannabis.”
Health Minister Ya’acov Litzman said that he was initially opposed to allowing the export of medical cannabis, but “due to the international interest in Israeli medical cannabis because of its professional quality and the economic potential, we have agreed with the Finance Ministry to approve the export of medical cannabis under certain restrictions and to countries where there is legal approval. We will ensure that our health sector benefits as a result of the increase in state revenues.”